Selective Fetal Growth Restriction Type III: Application of a Recent Expert Consensus Definition.


Journal

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547

Informations de publication

Date de publication:
Jul 2022
Historique:
revised: 31 08 2021
received: 29 04 2021
accepted: 11 09 2021
pubmed: 21 10 2021
medline: 16 6 2022
entrez: 20 10 2021
Statut: ppublish

Résumé

Per a recent expert definition, diagnosis of selective fetal growth restriction (sFGR) in monochorionic diamniotic twins is based on an estimated fetal weight (EFW) <3% as sole criterion and/or combinations of 4 contributory criteria (1 twin EFW <10%; 1 twin abdominal circumference <10%; EFW discordance ≥25%; and smaller twin umbilical artery [UA] pulsatility index >95th percentile). We assessed these criteria in sFGR Type III (intermittent absent or reversed end-diastolic flow of the UA [iAREDF]) patients to test whether meeting the more stringent parameters of the consensus definition had worse outcomes, that is, progression to sFGR Type II (persistent AREDF) or twin-twin transfusion syndrome; or secondarily, decreased dual survivorship. This was a retrospective study of referred sFGR Type III patients (2006-2017). Patients were retrospectively categorized using consensus criteria for 2 comparisons: 1) EFW <3% versus remaining cohort; 2) EFW <3% or met all 4 contributory criteria versus remaining cohort. Forty-eight patients were studied. Comparison 1: EFW <3% patients (58.3%) were not more likely to demonstrate disease progression (46.4% versus 65.0%, P = .2489) or worse dual survivorship (78.6% versus 85.0%, P = .7161). Comparison 2: EFW <3% or met all 4 contributory criteria (75.0%) patients were not more likely than the others to demonstrate progression (44.4% versus 83.3%, P = .0235) or worse dual survivorship (80.6% versus 83.3%, P = 1.0000). In a referred cohort of sFGR Type III patients, there was no evidence that meeting more stringent parameters of the consensus definition was associated with disease progression or dual survivorship.

Identifiants

pubmed: 34668582
doi: 10.1002/jum.15847
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1657-1666

Informations de copyright

© 2021 American Institute of Ultrasound in Medicine.

Références

Acosta-Rojas R, Becker J, Munoz-Abellana B, Ruiz C, Carreras E, Gratacos E. Twin chorionicity and the risk of adverse perinatal outcome. Int J Gynaecol Obstet 2007; 96:98-102. https://doi.org/10.1016/j.ijgo.2006.11.002.
Gratacos E, Ortiz JU, Martinez JM. A systematic approach to the differential diagnosis and management of the complications of monochorionic twin pregnancies. Fetal Diagn Ther 2012; 32:145-155. https://doi.org/10.1159/000342751.
Lewi L. Monochorionic diamniotic twins: what do I tell the prospective parents? Prenat Diagn 2020; 40:766-775. https://doi.org/10.1002/pd.5705.
Chalouhi GE, Stirnemann JJ, Salomon LJ, Essaoui M, Quibel T, Ville Y. Specific complications of monochorionic twin pregnancies: twin-twin transfusion syndrome and twin reversed arterial perfusion sequence. Semin Fetal Neonatal Med 2010; 15:349-356. https://doi.org/10.1016/j.siny.2010.09.003.
Bennasar M, Eixarch E, Martinez JM, Gratacos E. Selective intrauterine growth restriction in monochorionic diamniotic twin pregnancies. Semin Fetal Neonatal Med 2017; 22:376-382. https://doi.org/10.1016/j.siny.2017.05.001.
Buca D, Pagani G, Rizzo G, et al. Outcome of monochorionic twin pregnancy with selective intrauterine growth restriction according to umbilical artery Doppler flow pattern of smaller twin: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2017; 50:559-568. https://doi.org/10.1002/uog.17362.
Groene SG, Tollenaar LSA, Oepkes D, Lopriore E, van Klink JMM. The impact of selective fetal growth restriction or birth weight discordance on long-term neurodevelopment in Monochorionic twins: a systematic literature review. J Clin Med 2019; 8:944. https://doi.org/10.3390/jcm8070944.
Rustico MA, Consonni D, Lanna M, et al. Selective intrauterine growth restriction in monochorionic twins: changing patterns in umbilical artery Doppler flow and outcomes. Ultrasound Obstet Gynecol 2017; 49:387-393. https://doi.org/10.1002/uog.15933.
Gratacos E, Lewi L, Munoz B, et al. A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin. Ultrasound Obstet Gynecol 2007; 30:28-34. https://doi.org/10.1002/uog.4046.
Couck I, Ponnet S, Deprest J, Devlieger R, De Catte L, Lewi L. Outcome of monochorionic twin pregnancy with selective fetal growth restriction at 16, 20 or 30 weeks according to new Delphi consensus definition. Ultrasound Obstet Gynecol 2020; 56:821-830. https://doi.org/10.1002/uog.21975.
Ishii K, Nakata M, Wada S, Murakoshi T, Sago H. Feasibility and preliminary outcomes of fetoscopic laser photocoagulation for monochorionic twin gestation with selective intrauterine growth restriction accompanied by severe oligohydramnios. J Obstet Gynaecol Res 2015; 41:1732-1737. https://doi.org/10.1111/jog.12827.
Parra-Cordero M, Bennasar M, Martinez JM, Eixarch E, Torres X, Gratacos E. Cord occlusion in monochorionic twins with early selective intrauterine growth restriction and abnormal umbilical artery Doppler: a consecutive series of 90 cases. Fetal Diagn Ther 2016; 39:186-191. https://doi.org/10.1159/000439023.
Peeva G, Bower S, Orosz L, Chaveeva P, Akolekar R, Nicolaides KH. Endoscopic placental laser coagulation in monochorionic diamniotic twins with type II selective fetal growth restriction. Fetal Diagn Ther 2015; 38:86-93. https://doi.org/10.1159/000374109.
Shinar S, Xing W, Pruthi V, et al. Outcomes of monochorionic twin pregnancies complicated by type-III selective fetal growth restriction. Ultrasound Obstet Gynecol 2020; 57:126-133. https://doi.org/10.1002/uog.23515.
Sukhwani M, Antolin E, Herrero B, et al. Management and perinatal outcome of selective intrauterine growth restriction in monochorionic pregnancies. J Matern Fetal Neonatal Med 2019; 3:1-6. https://doi.org/10.1080/14767058.2019.1698030.
Khalil A, Rodgers M, Baschat A, et al. ISUOG practice guidelines: role of ultrasound in twin pregnancy. Ultrasound Obstet Gynecol 2016; 47:247-263. https://doi.org/10.1002/uog.15821.
Badr DA, Carlin A, Kang X, et al. Evaluation of the new expert consensus-based definition of selective fetal growth restriction in monochorionic pregnancies. J Matern Fetal Neonatal Med 2020; 6:1-7. https://doi.org/10.1080/14767058.2020.1786053.
Khalil A, Beune I, Hecher K, et al. Consensus definition and essential reporting parameters of selective fetal growth restriction in twin pregnancy: a Delphi procedure. Ultrasound Obstet Gynecol 2019; 53:47-54. https://doi.org/10.1002/uog.19013.
Donepudi R, Espinoza J, Nassr AA, Belfort MA, Shamshirsaz AA, Sanz CM. Prediction of fetal death in selective growth restriction complicating twin-twin transfusion syndrome using standardized definitions. Ultrasound Obstet Gynecol 2020; 58:738-743.
Ishii K, Murakoshi T, Takahashi Y, et al. Perinatal outcome of monochorionic twins with selective intrauterine growth restriction and different types of umbilical artery Doppler under expectant management. Fetal Diagn Ther 2009; 26:157-161. https://doi.org/10.1159/000253880.
Quintero RA, Bornick PW, Morales WJ, Allen MH. Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation. Am J Obstet Gynecol 2001; 185:689-696. https://doi.org/10.1067/mob.2001.116724.
Chmait RH, Chon AH, Korst LM, Stephen Y, Llanes A, Ouzounian JG. Selective intrauterine growth restriction (SIUGR) type II: proposed subclassification to guide surgical management. J Matern Fetal Neonatal Med 2020; 31:1-8. https://doi.org/10.1080/14767058.2020.1745177.
Gratacos E, Antolin E, Lewi L, et al. Monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic flow (Type III): feasibility and perinatal outcome of fetoscopic placental laser coagulation. Ultrasound Obstet Gynecol 2008; 31:669-675. https://doi.org/10.1002/uog.5362.
Chon AH, Ma SY, Korst LM, Chmait HR, Purnell ME, Chmait RH. Antenatal course of referred monochorionic diamniotic twins complicated by selective intrauterine growth restriction (SIUGR) type III. J Matern Fetal Neonatal Med 2019; 16:1-7. https://doi.org/10.1080/14767058.2019.1701648.
Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO study. Am J Obstet Gynecol 2013; 208:290 e1-290 e6. https://doi.org/10.1016/j.ajog.2013.02.007.
Savchev S, Figueras F, Cruz-Martinez R, Illa M, Botet F, Gratacos E. Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices. Ultrasound Obstet Gynecol 2012; 39:299-303. https://doi.org/10.1002/uog.10150.
Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol 1999; 19:550-555.
Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991; 181:129-133. https://doi.org/10.1148/radiology.181.1.1887021.
Ishii K, Murakoshi T, Hayashi S, et al. Ultrasound predictors of mortality in monochorionic twins with selective intrauterine growth restriction. Ultrasound Obstet Gynecol 2011; 37:22-26. https://doi.org/10.1002/uog.8846.
Chmait RH, Kontopoulos EV, Korst LM, Llanes A, Petisco I, Quintero RA. Stage-based outcomes of 682 consecutive cases of twin-twin transfusion syndrome treated with laser surgery: the USFetus experience. Am J Obstet Gynecol 2011; 204:393 e1-393 e6. https://doi.org/10.1016/j.ajog.2011.02.001.
Van Winden KR, Quintero RA, Kontopoulos EV, Korst LM, Llanes A, Chmait RH. Perinatal survival in cases of twin-twin transfusion syndrome complicated by selective intrauterine growth restriction. J Matern Fetal Neonatal Med 2015; 28:1549-1553. https://doi.org/10.3109/14767058.2014.960834.
Curado J, Sileo F, Bhide A, Thilaganathan B, Khalil A. Early- and late-onset selective fetal growth restriction in monochorionic diamniotic twin pregnancy: natural history and diagnostic criteria. Ultrasound Obstet Gynecol 2020; 55:661-666. https://doi.org/10.1002/uog.20849.
Khalil A, Liu B. Controversies in the management of twin pregnancy. Ultrasound Obstet Gynecol 2021; 57:888-902. https://doi.org/10.1002/uog.22181.
Townsend R, Duffy JMN, Sileo F, et al. Core outcome set for studies investigating management of selective fetal growth restriction in twins. Ultrasound Obstet Gynecol 2020; 55:652-660. https://doi.org/10.1002/uog.20388.
Martins JG, Biggio JR, Abuhamad A, Society for Maternal-Fetal Medicine. Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol 2020; 223:B2-B17. https://doi.org/10.1016/j.ajog.2020.05.010.

Auteurs

Sami R Chmait (SR)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Martha A Monson (MA)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Lisa M Korst (LM)

Childbirth Research Associates, North Hollywood, CA, USA.

Arlyn Llanes (A)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Andrew H Chon (AH)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH